Results 11 to 20 of about 2,978 (173)

RIPK3 and kidney disease

open access: yesNefrología (English Edition), 2023
Receptor interacting protein kinase 3 (RIPK3) is an intracellular kinase at the crossroads of cell death and inflammation. RIPK3 contains a RIP homotypic interaction motif (RHIM) domain which allows interactions with other RHIM-containing proteins and a ...
Juan Guerrero-Mauvecin   +4 more
doaj   +9 more sources

PRMT5-mediated regulatory arginine methylation of RIPK3

open access: yesCell Death Discovery, 2023
The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase ...
Chanchal Chauhan   +7 more
doaj   +6 more sources

RIPK3: Beyond Necroptosis. [PDF]

open access: yesImmunity, 2021
In this issue of Immunity, Daniels et al. (2019) demonstrate that RIPK3 signaling limits Zika virus (ZIKV) infection in the central nervous system independently of its function in necroptosis by promoting itaconate production in infected neurons, thereby
Evans, Azia S, Coyne, Carolyn B
core   +3 more sources

Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling

open access: yesCell Death and Disease, 2022
Necroptosis is a caspase-independent, pro-inflammatory mode of programmed cell death which relies on the activation of the terminal effector, MLKL, by the upstream protein kinase RIPK3.
Yanxiang Meng   +7 more
doaj   +2 more sources

RIPK1 and RIPK3 - emerging targets in cancer?

open access: yesMolecular and Cellular Therapies, 2018
RIPK1 and RIPK3 are homologous Ser/Thr kinases, which act in concert within the necrosome complexes to initiate a sub-type of regulated necrosis, termed necroptosis.
Suraj Shah, Kerem Gurol, Alexei Degterev
core   +3 more sources

RIPK3—a predictive marker for personalized immunotherapy? [PDF]

open access: yesOncoImmunology, 2016
Cancer immunotherapy is an attractive therapeutic option but it is currently unclear which patient may benefit from such approaches. Using the model of cervical cancer, we have demonstrated that PolyIC-driven immunogenicity strictly depends on the ...
Sigrun Smola
core   +4 more sources

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

open access: yesHepatology, EarlyView., 2022
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Abstract Background and Aims Receptor‐interacting protein kinase 3 (RIPK3) mediates NAFLD progression, but its metabolic function is unclear. Here, we aimed to investigate the role of RIPK3 in modulating mitochondria function, coupled with lipid droplet (LD)
Marta B. Afonso   +16 more
wiley   +2 more sources

Necroptosis induced by RIPK3 requires MLKL but not Drp1 [PDF]

open access: yesCell Death & Disease, 2014
Necroptosis is a mechanism by which cells can kill themselves that does not require caspase activity or the presence of the pro-apoptotic Bcl-2 family members Bax or Bak.
Vaux, DL   +3 more
core   +5 more sources

RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis [PDF]

open access: yesCell Death and Disease, 2023
Necroptosis facilitates cell death in a controlled manner and is employed by many cell types following injury. It plays a significant role in various liver diseases, albeit the cell-type-specific regulation of necroptosis in the liver and especially ...
Jessica Hoff   +7 more
doaj   +2 more sources

Spotted: RIPK3 and MLKL assembling necroptotic complexes

open access: yesOpen Biology
Necroptosis is a form of regulated cell death (RCD) that evolved as a defence against pathogenic infection. Unlike caspase-dependent RCD, necroptosis, in its canonical form, is driven by receptor-interacting protein kinase 1 and 3 (RIPK1 and RIPK3 ...
Martínez-Osorio, V.   +2 more
core   +4 more sources

Home - About - Disclaimer - Privacy